Moreover, the interplay between PAPP-A and IGF1 may influence other pathways crucial for tumor progression, such as PI3K/AKT and MAPK/ERK signaling, further enhancing breast cancer cell proliferation, survival, and metastasis. This evidence concerns the gene IGF1 and breast carcinoma.